Q2 2024
Released Aug 8, 2024, after the close
10-Q filed Aug 8, 2024, 39 days after period end · 0000950170-24-094092
Q2 2024 · 10-Q
Revenue—
Net Income-$2.63M-$2.63M no prior Q2 2023 on fileN/M vs Q1 2024
EPS Diluted-$0.05-$0.05 no prior Q2 2023 on fileN/M vs Q1 2024
Operating Income-$3,046,496—
Operating Cash Flowderived-$2,810,930—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2024 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Net Income | -$2.63M | -$4.45M | -$3.88M | -$3.14M |
| EPS Diluted | -$0.05 | -$0.10 | -$0.09 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR